Quick Links
 

Lungs & Breathing

Lungs & Breathing

Participate in Research is designed to connect potential volunteers with open research studies. We are looking for volunteers just like you to help answer important questions about lungs and breathing. This page lists lungs and breathing studies that may apply to you or someone you know. If you find a study that you’d like to participate in, you can contact the study team with questions or to volunteer. Join us to improve the health of others.

More Information

UW Medicine Lung Care and Lung Transplantation Services
UW Medicine

UW Medicine’s lung care and lung transplantation services, located at Harborview and UW Medical Center in Seattle, combine pulmonary and critical care medicine, thoracic surgery and lung transplantation to provide the highest quality patient care for the entire spectrum of pulmonary and critical care illnesses.

Active Studies

  • Thank you for your interest in the UW Smartphone Cough Study! The purpose of this study is to collect cough data for our cough detection smartphone app. This app has the potential to make a big impact in the fight against the COVID-19 outbreak so......

  • UW Medicine and Bloodworks Northwest are seeking adult volunteers who have recovered from documented SARS-CoV-2 (COVID-19) infection to be considered for donation of plasma. Plasma is the liquid component of blood that contains various proteins. Antibodies are proteins in plasma that defend your body against......

  • The purpose of this study is to assess the effectiveness of hydroxychloroquine (HCQ) or HCQ/azithromycin for the treatment of SARS-CoV-2 infection (the virus that causes COVID-19) in those adults who have been diagnosed with the virus. We plan on enrolling 635 participants from sites all......

  • Post-exposure prophylaxis (PEP) is defined as taking antimicrobial medication after being exposed or potentially exposed to an infectious agent to prevent becoming infected. PEP is routinely used for prevention of a variety of viral, bacterial, and parasitic infections, including influenza and human immunodeficiency virus (HIV).......

  • Effective therapies for COVID-19 are urgently needed. There has yet to be a well-designed, fully-powered, placebo-controlled trial to determine the potential efficacy of these drugs in any stage of COVID-19, yet alone to stop the progression of disease. The National Institute of Allergy and Infectious......

  • This is a natural history study to define the contribution of known vEDS gene mutations to vEDS complications and outcomes. This will be achieved by the following: 1. Describe the genotype-phenotype correlation between vEDS gene mutations and complications. These complications include aortic and arterial pathology......

  • This Phase 2b study is designed to evaluate the treatment effect (change in forced vital capacity [FVC]) of a single dose of BG00011 (56 mg) administered subcutaneously (SC) once weekly for 52 weeks in subjects with mild to moderate idiopathic pulmonary fibrosis (IPF) who may......

SITE PARTNERS
uw-footer